Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer. [electronic resource]
Producer: 20170712Description: e0157830 p. digitalISSN:- 1932-6203
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Caco-2 Cells
- Cell Proliferation -- drug effects
- Cell- and Tissue-Based Therapy
- Cetuximab -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- HT29 Cells
- Humans
- Immunoglobulin G -- immunology
- Killer Cells, Natural
- Mutation
- Neoplasm Metastasis
- Proto-Oncogene Proteins B-raf -- genetics
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.